FDA Approved: SECUADO — Supplemental Application (Noven Therapeutics, LLC)

View source ↗

Summary

The FDA approved a supplemental application for SECUADO (asenapine) submitted by Noven Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SECUADO (ASENAPINE)

Snippet

SUPPL AP for SECUADO (ASENAPINE)